Home > Healthcare > Iliac Stents Market > Table of Contents

Iliac Stents Market - By Type (Self-expandable, Balloon-Expandable, Covered Stents), Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, Complete Obstructive Lesions), End-use (Hospital, ASCs), & Global Forecast 2024 – 2032

  • Report ID: GMI8576
  • Published Date: Mar 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definition

1.2    Base estimates & calculations

1.3    Data collection

1.4    Forecast parameters

1.5    Data validation

1.6    Data sources

1.6.1    Primary

1.6.2    Secondary

1.6.2.1   Paid sources

1.6.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Increasing prevalence of peripheral artery disease (PAD)

3.2.1.2   Technological advancements in stents design and materials

3.2.1.3   Rising demand for minimally invasive procedures

3.2.2    Industry pitfalls & challenges

3.2.2.1   Stringent regulatory approvals

3.2.2.2   Lack of reimbursement policies

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Technological landscape

3.6    Reimbursement scenario

3.7    Porter's analysis

3.7.1    Supplier power

3.7.2    Buyer power

3.7.3    Threat of new entrants

3.7.4    Threat of substitutes

3.7.5    Industry rivalry

3.8    PESTEL analysis

3.9    Future market trends

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Company market share analysis

4.4    Competitive positioning matrix

4.5    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Type, 2018 – 2032 ($ Mn)

5.1    Key trends

5.2    Self-expandable stents

5.3    Balloon-expandable stents

5.4    Covered stents

Chapter 6   Market Estimates and Forecast, By Artery Lesions, 2018 – 2032 ($ Mn)

6.1    Key trends

6.2    Common iliac artery lesions

6.3    Severe calcified lesions

6.4    Complete obstructive lesions

Chapter 7   Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)

7.1    Key trends

7.2    Hospitals

7.3    Ambulatory surgical centers

7.4    Other end-users

Chapter 8   Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)

8.1    Key trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Italy

8.3.5    Spain

8.3.6    Rest of Europe

8.4    Asia Pacific

8.4.1    China

8.4.2    Japan

8.4.3    India

8.4.4    Australia

8.4.5    South Korea

8.4.6    Rest of Asia Pacific

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Argentina

8.5.4    Rest of Latin America

8.6    Middle East and Africa

8.6.1    Saudi Arabia

8.6.2    South Africa

8.6.3    UAE

8.6.4    Rest of Middle East and Africa

Chapter 9   Company Profiles

9.1    Abbott Laboratories

9.2    Alvimedica

9.3    Becton, Dickinson and Company

9.4    Biotronik

9.5    Boston Scientific Corporation

9.6    B. Braun SE

9.7    Cook

9.8    Getinge AB

9.9    iVascular

9.10    Medtronic Plc

   

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 189
  • Countries covered: 22
  • Pages: 110
 Download Free Sample